SM
PVLA

Sabby Management’s Palvella Therapeutics PVLA Stock Holding History

Sabby Management’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-16,200
Closed -$1.81M – 326
2016
Q4 		$1.81M Sell
16,200
-3,091
-16% -$383K 0.11% 109
2016
Q3 		$2.82M Sell
19,291
-909
-5% -$121K 0.11% 103
2016
Q2 		$2.6M Buy
20,200
+18,012
+823% +$2.76M 0.14% 88
2016
Q1 		$333K Buy
2,188
+1,248
+133% +$176K 0.02% 238
2015
Q4 		$172K Sell
940
-944
-50% -$158K 0.01% 286
2015
Q3 		$276K Buy
+1,884
New +$420K 0.01% 330

Other funds holding PVLA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return